Wellnex Life Limited (AIM:WNX)

Market Cap	7.42M
Revenue (ttm)	11.31M
Net Income (ttm)	-7.47M
Shares Out	n/a
EPS (ttm)	-0.26
PE Ratio	n/a
Forward PE	16.94
Dividend	n/a
Ex-Dividend Date	n/a

Volume	47,000
Average Volume	26,261
Open	13.50
Previous Close	13.50
Day's Range	13.50 - 13.50
52-Week Range	0.15 - 31.30
Beta	n/a
RSI	45.54
Earnings Date	Dec 12, 2025

About Wellnex Life

Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness products in Australia, New Zealand, and the United Kingdom. The company offers topical anti-inflammatory creams, sprays, and roll-ons under the Pain Away brand; caffeine energy liquid capsules and multivitamins under the Wakey Wakey brand; sleep aid products under the Nighty Night brand; teeth whitening solutions under the Mr. Bright brand; pain relief capsules under the Wagner Liquigesics brand; medicinal cannabis under the Wellness Life bran...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2011
• Country: Australia
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: WNX

Financial Performance

In 2025, Wellnex Life's revenue was 23.63 million, an increase of 40.39% compared to the previous year's 16.83 million. Losses were -15.60 million, 13.6% more than in 2024.

Financial numbers in AUD